Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Clofazimine in the treatment of pyoderma gangrenosum.

Clofazimine in the treatment of pyoderma gangrenosum. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Clofazimine in the treatment of pyoderma gangrenosum. Abstract Text:

    Ten patients with pyoderma gangrenosum, seven female and three male, 25 to 94 years old, mainly with multiple lesions, have been treated with clofazimine, 100 mg three times daily. Associated disease was registered in three patients: diabetes mellitus, a previous adenocarcinoma of the colon treated by hemicolectomy, and pustulosis palmoplantaris. In a further patient, M-component was found in the serum. In seven cases the lesions were completely healed by two to five months of therapy, and in three cases the ulcers healed partially. Side effects were redness of the skin in seven cases and dryness of the skin in two patients. No hematological side effects occurred. The working mechanism is still obscure.

    Clofazimine in the treatment of pyoderma gangrenosum. Publishing Authors By Initials

    For similar skin and connective tissue diseases: skin diseases: pyoderma research abstracts see: skin and connective tissue diseases: skin diseases: pyoderma research

    PUBMED ID PMID:

    MEDLINE DATE:

    Clofazimine in the treatment of pyoderma gangrenosum. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Archives of dermatology

    VOLUME: 115

    Page Numbers: 851-2

    Journal Abbreviation: Arch Dermatol

    ISSN: 0003-987X

    DAY: 17

    MONTH: Jul

    YEAR: 1979

    Clofazimine in the treatment of pyoderma gangrenosum. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372433

    Clofazimine in the treatment of pyoderma gangrenosum. Keywords Mesh Terms:

    KEYWORDS: Pyoderma

    MESH TERMS: drug therapy

    Chemical & Substance for Abstract: Clofazimine in the treatment of pyoderma gangrenosum. Information

    Substance Name: Clofazimine

    Registry Number: 2030-63-9

    Grant and Affiliation Information for Clofazimine in the treatment of pyoderma gangrenosum.

    AFFILIATION:

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Arch Dermatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Clofazimine in the treatment of pyoderma gangrenosum Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News